{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T14:02:40Z","timestamp":1795183360629,"version":"4.10.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82003099"],"award-info":[{"award-number":["82003099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82003099"],"award-info":[{"award-number":["82003099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82003099"],"award-info":[{"award-number":["82003099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82003099"],"award-info":[{"award-number":["82003099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82003099"],"award-info":[{"award-number":["82003099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82003099"],"award-info":[{"award-number":["82003099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82003099"],"award-info":[{"award-number":["82003099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82003099"],"award-info":[{"award-number":["82003099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82003099"],"award-info":[{"award-number":["82003099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82003099"],"award-info":[{"award-number":["82003099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82003099"],"award-info":[{"award-number":["82003099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82003099"],"award-info":[{"award-number":["82003099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82003099"],"award-info":[{"award-number":["82003099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82003099"],"award-info":[{"award-number":["82003099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82003099"],"award-info":[{"award-number":["82003099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82003099"],"award-info":[{"award-number":["82003099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2020-4-20410"],"award-info":[{"award-number":["2020-4-20410"]}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2020-4-20410"],"award-info":[{"award-number":["2020-4-20410"]}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2020-4-20410"],"award-info":[{"award-number":["2020-4-20410"]}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2020-4-20410"],"award-info":[{"award-number":["2020-4-20410"]}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2020-4-20410"],"award-info":[{"award-number":["2020-4-20410"]}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2020-4-20410"],"award-info":[{"award-number":["2020-4-20410"]}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2020-4-20410"],"award-info":[{"award-number":["2020-4-20410"]}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2020-4-20410"],"award-info":[{"award-number":["2020-4-20410"]}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2020-4-20410"],"award-info":[{"award-number":["2020-4-20410"]}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2020-4-20410"],"award-info":[{"award-number":["2020-4-20410"]}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2020-4-20410"],"award-info":[{"award-number":["2020-4-20410"]}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2020-4-20410"],"award-info":[{"award-number":["2020-4-20410"]}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2020-4-20410"],"award-info":[{"award-number":["2020-4-20410"]}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2020-4-20410"],"award-info":[{"award-number":["2020-4-20410"]}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2020-4-20410"],"award-info":[{"award-number":["2020-4-20410"]}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2020-4-20410"],"award-info":[{"award-number":["2020-4-20410"]}]},{"name":"Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes","award":["JYY2018-7"],"award-info":[{"award-number":["JYY2018-7"]}]},{"name":"Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes","award":["JYY2018-7"],"award-info":[{"award-number":["JYY2018-7"]}]},{"name":"Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes","award":["JYY2018-7"],"award-info":[{"award-number":["JYY2018-7"]}]},{"name":"Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes","award":["JYY2018-7"],"award-info":[{"award-number":["JYY2018-7"]}]},{"name":"Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes","award":["JYY2018-7"],"award-info":[{"award-number":["JYY2018-7"]}]},{"name":"Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes","award":["JYY2018-7"],"award-info":[{"award-number":["JYY2018-7"]}]},{"name":"Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes","award":["JYY2018-7"],"award-info":[{"award-number":["JYY2018-7"]}]},{"name":"Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes","award":["JYY2018-7"],"award-info":[{"award-number":["JYY2018-7"]}]},{"name":"Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes","award":["JYY2018-7"],"award-info":[{"award-number":["JYY2018-7"]}]},{"name":"Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes","award":["JYY2018-7"],"award-info":[{"award-number":["JYY2018-7"]}]},{"name":"Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes","award":["JYY2018-7"],"award-info":[{"award-number":["JYY2018-7"]}]},{"name":"Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes","award":["JYY2018-7"],"award-info":[{"award-number":["JYY2018-7"]}]},{"name":"Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes","award":["JYY2018-7"],"award-info":[{"award-number":["JYY2018-7"]}]},{"name":"Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes","award":["JYY2018-7"],"award-info":[{"award-number":["JYY2018-7"]}]},{"name":"Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes","award":["JYY2018-7"],"award-info":[{"award-number":["JYY2018-7"]}]},{"name":"Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes","award":["JYY2018-7"],"award-info":[{"award-number":["JYY2018-7"]}]},{"name":"Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes","award":["JYY2018-7"],"award-info":[{"award-number":["JYY2018-7"]}]},{"name":"Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes","award":["JYY2018-7"],"award-info":[{"award-number":["JYY2018-7"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Genetic and epigenetic profiles are critical in managing brainstem gliomas (BSG), whose heterogeneity is far beyond the realm of the Diffuse midline glioma, H3K27 altered. Cerebrospinal fluid (CSF) circulating tumor DNA (ctDNA)-based liquid biopsy provides minimally-invasive strategies to acquire molecular information for brain tumors, whereas there is a deficiency in techniques for co-detection of genetic and epigenetic alterations due to the limited yield of ctDNA. This study aims to develop a reliable minimally-invasive approach to simultaneously detect the mutation and methylation profiles in the CSF ctDNA of BSGs, thereby enhancing diagnostic accuracy, prognostic capability, and monitoring potential.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A cohort of 80 BSG cases with 138 CSF samples and 71 tissues was retrospectively established. Public tissue methylation profiles (<jats:italic>N<\/jats:italic>\u2009=\u20091016) were used for the development of H3K27M and IDH mutation-specific assay. The mutation and methylation co-detection classifier (BSGdiag) was trained and tested in tissue cohorts and further validated in CSF samples. CSF Methylation Risk Score (MRS) was defined and used for prognostication and monitoring.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The methylation assay demonstrated robust three-class (H3K27M-mut, IDH-mut and double-wildtype) classification with microAUC values of 1.00, 0.973, and 0.813 across public datasets, tissue cohorts, and CSF samples, respectively. BSGdiag achieved a sensitivity of 95.6%, specificity of 83.3%, and AUC of 0.949 for the H3K27M subtype, and a microAUC of 0.990 for the three-class classification in CSFs. MRS-stratified CSF methylation risk group was an independent prognostic factor (HR\u2009=\u20092.61, 95% CI: 1.09\u20136.25, <jats:italic>P<\/jats:italic>\u2009=\u20090.032). Methylation information in CSF remained even with clinical, radiological and CSF genetic indications of no disease, suggesting its utility in monitoring minimal residual disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The study de novo developed the first methylation assay for robust BSG molecular subtyping and introduced a novel methodology for co-detecting CSF ctDNA mutations and methylation in BSGs. The BSGdiag enhances the utility of ctDNA by leveraging both genetic and epigenetic information. Its comprehensiveness, minimal invasiveness, robustness, and reliability make it highly promising for future clinical applications and trial designs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13046-025-03455-y","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T04:43:37Z","timestamp":1759812217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Co-detection of mutations and methylations in cerebrospinal fluid ctDNA for minimally-invasive diagnosis of brainstem glioma"],"prefix":"10.1186","volume":"44","author":[{"given":"Tian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyao","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changchun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"issue":"8","key":"3455_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"2","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol Aug. 2021;2(8):1231\u201351. https:\/\/doi.org\/10.1093\/neuonc\/noab106.","journal-title":"Neuro Oncol Aug"},{"issue":"19","key":"3455_CR2","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2017.75.9308","volume":"1","author":"LM Hoffman","year":"2018","unstructured":"Hoffman LM, van Veldhuijzen SEM, Colditz N, et al. Clinical, radiologic, pathologic, and molecular characteristics of Long-Term survivors of diffuse intrinsic Pontine glioma (DIPG): A collaborative report from the international and European society for pediatric oncology DIPG registries. Journal Clin Oncology: Official J Am Soc Clin Oncology Jul. 2018;1(19):1963\u201372. https:\/\/doi.org\/10.1200\/JCO.2017.75.9308.","journal-title":"Journal Clin Oncology: Official J Am Soc Clin Oncology Jul"},{"key":"3455_CR3","doi-asserted-by":"publisher","unstructured":"Pan C, Zhang M, Xiao X, et al. Brainstem gliomas with isocitrate dehydrogenase mutation: natural history, Clinical-Radiological features, management strategy, and Long-Term outcome. Neurosurgery Jun. 2024;11. https:\/\/doi.org\/10.1227\/neu.0000000000003020.","DOI":"10.1227\/neu.0000000000003020"},{"key":"3455_CR4","doi-asserted-by":"publisher","unstructured":"Pan C, Li T, Zhang M et al. A novel radiological classification of midbrain pilocytic Astrocytomas and its implication for surgical management: a single-institution experience of 57 cases. J Neurosurg Dec 22 2023:1\u201313. https:\/\/doi.org\/10.3171\/2023.9.JNS23540","DOI":"10.3171\/2023.9.JNS23540"},{"issue":"7","key":"3455_CR5","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/ng.2995","volume":"46","author":"L Zhang","year":"2014","unstructured":"Zhang L, Chen LH, Wan H, et al. Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas. Nature Genetics Jul. 2014;46(7):726\u201330. https:\/\/doi.org\/10.1038\/ng.2995.","journal-title":"Nature Genetics Jul"},{"key":"3455_CR6","doi-asserted-by":"publisher","unstructured":"Shan S, Chen J, Sun Y et al. Jul. Functionalized Macrophage Exosomes with Panobinostat and PPM1D-siRNA for Diffuse Intrinsic Pontine Gliomas Therapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2022;9(21):e2200353. https:\/\/doi.org\/10.1002\/advs.202200353","DOI":"10.1002\/advs.202200353"},{"issue":"1","key":"3455_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00401-023-02651-4","volume":"8","author":"L Auffret","year":"2023","unstructured":"Auffret L, Ajlil Y, Tauzi\u00e8de-Espariat A, et al. A new subtype of diffuse midline glioma, H3 K27 and BRAF\/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation. Acta Neuropathologica Dec. 2023;8(1):2. https:\/\/doi.org\/10.1007\/s00401-023-02651-4.","journal-title":"Acta Neuropathologica Dec"},{"issue":"2","key":"3455_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00401-018-1879-y","volume":"136","author":"D Capper","year":"2018","unstructured":"Capper D, Stichel D, Sahm F, et al. Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathologica Aug. 2018;136(2):181\u2013210. https:\/\/doi.org\/10.1007\/s00401-018-1879-y.","journal-title":"Acta Neuropathologica Aug"},{"issue":"1","key":"3455_CR9","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1038\/s41467-020-16682-y","volume":"17","author":"LH Chen","year":"2020","unstructured":"Chen LH, Pan C, Diplas BH, et al. The integrated genomic and epigenomic landscape of brainstem glioma. Nature Communications Jun. 2020;17(1):3077. https:\/\/doi.org\/10.1038\/s41467-020-16682-y.","journal-title":"Nature Communications Jun"},{"issue":"7697","key":"3455_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"22","author":"D Capper","year":"2018","unstructured":"Capper D, Jones DTW, Sill M, et al. DNA methylation-based classification of central nervous system tumours. Nature Mar. 2018;22(7697):469\u201374. https:\/\/doi.org\/10.1038\/nature26000.","journal-title":"Nature Mar"},{"key":"3455_CR11","doi-asserted-by":"publisher","unstructured":"Zuccato JA, Patil V, Mansouri S et al. Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification. Neuro-oncology. Aug 3. 2023;25(8):1452\u20131460. https:\/\/doi.org\/10.1093\/neuonc\/noac264","DOI":"10.1093\/neuonc\/noac264"},{"issue":"5","key":"3455_CR12","doi-asserted-by":"publisher","first-page":"e13233","DOI":"10.1111\/bpa.13233","volume":"34","author":"T Kling","year":"2024","unstructured":"Kling T, Ferreyra Vega S, Suman M, et al. Refinement of prognostication for IDH-mutant Astrocytomas using DNA methylation-based classification. Brain Pathol (Zurich Switzerland) Sep. 2024;34(5):e13233. https:\/\/doi.org\/10.1111\/bpa.13233.","journal-title":"Brain Pathol (Zurich Switzerland) Sep"},{"issue":"5","key":"3455_CR13","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2016.01.015","volume":"25","author":"D Sturm","year":"2016","unstructured":"Sturm D, Orr BA, Toprak UH, et al. New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell Feb. 2016;25(5):1060\u201372. https:\/\/doi.org\/10.1016\/j.cell.2016.01.015.","journal-title":"Cell Feb"},{"issue":"5","key":"3455_CR14","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ccell.2015.04.002","volume":"11","author":"KW Pajtler","year":"2015","unstructured":"Pajtler KW, Witt H, Sill M, et al. Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell. May 2015;11(5):728\u201343. https:\/\/doi.org\/10.1016\/j.ccell.2015.04.002.","journal-title":"Cancer Cell"},{"key":"3455_CR15","doi-asserted-by":"publisher","unstructured":"Nabors B, Portnow J, Hattangadi-Gluth J, Horbinski C. NCCN CNS tumor guidelines update for 2023. Neuro-oncology. Dec 8. 2023;25(12):2114\u20132116. https:\/\/doi.org\/10.1093\/neuonc\/noad169","DOI":"10.1093\/neuonc\/noad169"},{"key":"3455_CR16","doi-asserted-by":"publisher","unstructured":"Sahm F, Brandner S, Bertero L et al. Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline. Neuro-oncology. Oct 3. 2023;25(10):1731\u20131749. https:\/\/doi.org\/10.1093\/neuonc\/noad100","DOI":"10.1093\/neuonc\/noad100"},{"key":"3455_CR17","doi-asserted-by":"publisher","unstructured":"Odia Y, Koschmann C, Vitanza NA et al. Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma. Neuro-oncology. May 3. 2024;26(Supplement_2):S155-s164. https:\/\/doi.org\/10.1093\/neuonc\/noae001","DOI":"10.1093\/neuonc\/noae001"},{"key":"3455_CR18","doi-asserted-by":"publisher","unstructured":"van den Bent M, Saratsis AM, Geurts M, Franceschi E. H3 K27M-altered glioma and diffuse intrinsic pontine glioma: Semi-systematic review of treatment landscape and future directions. Neuro-oncology. May 3. 2024;26(Supplement_2):S110-s124. https:\/\/doi.org\/10.1093\/neuonc\/noad220","DOI":"10.1093\/neuonc\/noad220"},{"key":"3455_CR19","doi-asserted-by":"publisher","unstructured":"Persson ML, Douglas AM, Alvaro F et al. The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies. Neuro-oncology. Sep 1. 2022;24(9):1408\u20131422. https:\/\/doi.org\/10.1093\/neuonc\/noac117","DOI":"10.1093\/neuonc\/noac117"},{"issue":"7","key":"3455_CR20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1056\/NEJMoa2304194","volume":"17","author":"IK Mellinghoff","year":"2023","unstructured":"Mellinghoff IK, van den Bent MJ, Blumenthal DT, et al. Vorasidenib in IDH1- or IDH2-Mutant Low-Grade glioma. The New Engl J Medicine Aug. 2023;17(7):589\u2013601. https:\/\/doi.org\/10.1056\/NEJMoa2304194.","journal-title":"The New Engl J Medicine Aug"},{"issue":"13","key":"3455_CR21","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1200\/jco.23.01134","volume":"1","author":"I Arrillaga-Romany","year":"2024","unstructured":"Arrillaga-Romany I, Gardner SL, Odia Y, et al. ONC201 (Dordaviprone) in recurrent H3 K27M-Mutant diffuse midline glioma. Journal Clin Oncology: Official J Am Soc Clin Oncology May. 2024;1(13):1542\u201352. https:\/\/doi.org\/10.1200\/jco.23.01134.","journal-title":"Journal Clin Oncology: Official J Am Soc Clin Oncology May"},{"issue":"7741","key":"3455_CR22","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41586-019-0882-3","volume":"565","author":"AM Miller","year":"2019","unstructured":"Miller AM, Shah RH, Pentsova EI, et al. Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid. Nature Jan. 2019;565(7741):654\u20138. https:\/\/doi.org\/10.1038\/s41586-019-0882-3.","journal-title":"Nature Jan"},{"issue":"2","key":"3455_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00401-018-1936-6","volume":"137","author":"C Pan","year":"2019","unstructured":"Pan C, Diplas BH, Chen X, et al. Molecular profiling of tumors of the brainstem by sequencing of CSF-derived Circulating tumor DNA. Acta Neuropathologica Feb. 2019;137(2):297\u2013306. https:\/\/doi.org\/10.1007\/s00401-018-1936-6.","journal-title":"Acta Neuropathologica Feb"},{"issue":"23","key":"3455_CR24","doi-asserted-by":"publisher","first-page":"5850","DOI":"10.1158\/1078-0432.Ccr-18-1345","volume":"1","author":"E Panditharatna","year":"2018","unstructured":"Panditharatna E, Kilburn LB, Aboian MS, et al. Clinically relevant and minimally invasive tumor surveillance of pediatric diffuse midline gliomas using Patient-Derived liquid biopsy. Clin Cancer Res Dec. 2018;1(23):5850\u20139. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-1345.","journal-title":"Clin Cancer Res Dec"},{"issue":"8","key":"3455_CR25","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1093\/neuonc\/noac030","volume":"1","author":"E Cantor","year":"2022","unstructured":"Cantor E, Wierzbicki K, Tarapore RS, et al. Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma. Neuro Oncol Aug. 2022;1(8):1366\u201374. https:\/\/doi.org\/10.1093\/neuonc\/noac030.","journal-title":"Neuro Oncol Aug"},{"issue":"1","key":"3455_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40478-019-0668-8","volume":"20","author":"Z Jaunmuktane","year":"2019","unstructured":"Jaunmuktane Z, Capper D, Jones DTW, et al. Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre. Acta Neuropathol Communications Feb. 2019;20(1):24. https:\/\/doi.org\/10.1186\/s40478-019-0668-8.","journal-title":"Acta Neuropathol Communications Feb"},{"issue":"7732","key":"3455_CR27","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41586-018-0703-0","volume":"563","author":"SY Shen","year":"2018","unstructured":"Shen SY, Singhania R, Fehringer G, et al. Sensitive tumour detection and classification using plasma cell-free DNA methylomes. Nature Nov. 2018;563(7732):579\u201383. https:\/\/doi.org\/10.1038\/s41586-018-0703-0.","journal-title":"Nature Nov"},{"key":"3455_CR28","doi-asserted-by":"publisher","unstructured":"Xiao D, Yan C, Li D et al. May. National brain tumour registry of China (NBTRC) statistical report of primary brain tumours diagnosed in China in years 2019\u20132020. The lancet regional health Western Pacific. 2023;34:100715. https:\/\/doi.org\/10.1016\/j.lanwpc.2023.100715","DOI":"10.1016\/j.lanwpc.2023.100715"},{"issue":"1","key":"3455_CR29","doi-asserted-by":"publisher","first-page":"e040055","DOI":"10.1136\/bmjopen-2020-040055","volume":"17","author":"L Zhang","year":"2021","unstructured":"Zhang L, Jia W, Ji N, et al. Construction of the National brain tumor registry of China for better management and more efficient use of data: a protocol. BMJ Open Jan. 2021;17(1):e040055. https:\/\/doi.org\/10.1136\/bmjopen-2020-040055.","journal-title":"BMJ Open Jan"},{"issue":"2","key":"3455_CR30","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00401-020-02259-y","volume":"141","author":"U Sch\u00fcller","year":"2021","unstructured":"Sch\u00fcller U, Iglauer P, Dorostkar MM, et al. Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations. Acta Neuropathologica Feb. 2021;141(2):323\u20135. https:\/\/doi.org\/10.1007\/s00401-020-02259-y.","journal-title":"Acta Neuropathologica Feb"},{"issue":"5","key":"3455_CR31","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/ng.2936","volume":"46","author":"P Buczkowicz","year":"2014","unstructured":"Buczkowicz P, Hoeman C, Rakopoulos P, et al. Genomic analysis of diffuse intrinsic Pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nature Genetics May. 2014;46(5):451\u20136. https:\/\/doi.org\/10.1038\/ng.2936.","journal-title":"Nature Genetics May"},{"issue":"5","key":"3455_CR32","doi-asserted-by":"publisher","first-page":"294","DOI":"10.18632\/aging.100742","volume":"7","author":"S Horvath","year":"2015","unstructured":"Horvath S, Mah V, Lu AT, et al. The cerebellum ages slowly according to the epigenetic clock. Aging May. 2015;7(5):294\u2013306. https:\/\/doi.org\/10.18632\/aging.100742.","journal-title":"Aging May"},{"issue":"672","key":"3455_CR33","doi-asserted-by":"publisher","first-page":"eabp8704","DOI":"10.1126\/scitranslmed.abp8704","volume":"23","author":"P Wang","year":"2022","unstructured":"Wang P, Song Q, Ren J, et al. Simultaneous analysis of mutations and methylations in Circulating cell-free DNA for hepatocellular carcinoma detection. Science Translational Medicine Nov. 2022;23(672):eabp8704. https:\/\/doi.org\/10.1126\/scitranslmed.abp8704.","journal-title":"Science Translational Medicine Nov"},{"issue":"7854","key":"3455_CR34","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-021-03363-z","volume":"592","author":"M Platten","year":"2021","unstructured":"Platten M, Bunse L, Wick A, et al. A vaccine targeting mutant IDH1 in newly diagnosed glioma. Nature Apr. 2021;592(7854):463\u20138. https:\/\/doi.org\/10.1038\/s41586-021-03363-z.","journal-title":"Nature Apr"},{"issue":"10","key":"3455_CR35","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1038\/s41591-023-02555-6","volume":"29","author":"N Grassl","year":"2023","unstructured":"Grassl N, Poschke I, Lindner K, et al. A H3K27M-targeted vaccine in adults with diffuse midline glioma. Nature Medicine Oct. 2023;29(10):2586\u201392. https:\/\/doi.org\/10.1038\/s41591-023-02555-6.","journal-title":"Nature Medicine Oct"},{"issue":"7903","key":"3455_CR36","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s41586-022-04489-4","volume":"603","author":"RG Majzner","year":"2022","unstructured":"Majzner RG, Ramakrishna S, Yeom KW, et al. GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas. Nature Mar. 2022;603(7903):934\u201341. https:\/\/doi.org\/10.1038\/s41586-022-04489-4.","journal-title":"Nature Mar"},{"issue":"1","key":"3455_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41591-023-02668-y","volume":"30","author":"LB Kilburn","year":"2024","unstructured":"Kilburn LB, Khuong-Quang DA, Hansford JR, et al. The type II RAF inhibitor Tovorafenib in relapsed\/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial. Nature Medicine Jan. 2024;30(1):207\u201317. https:\/\/doi.org\/10.1038\/s41591-023-02668-y.","journal-title":"Nature Medicine Jan"},{"issue":"6","key":"3455_CR38","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.3171\/2023.9.Jns23540","volume":"1","author":"C Pan","year":"2024","unstructured":"Pan C, Li T, Zhang M, et al. A novel radiological classification of midbrain pilocytic Astrocytomas and its implication for surgical management: a single-institution experience of 57 cases. Journal Neurosurgery Jun. 2024;1(6):1527\u201339. https:\/\/doi.org\/10.3171\/2023.9.Jns23540.","journal-title":"Journal Neurosurgery Jun"},{"issue":"3","key":"3455_CR39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11060-021-03890-9","volume":"155","author":"HG Vuong","year":"2021","unstructured":"Vuong HG, Le HT, Ngo TNM, et al. H3K27M-mutant diffuse midline gliomas should be further molecularly stratified: an integrated analysis of 669 patients. Journal neuro-oncology Dec. 2021;155(3):225\u201334. https:\/\/doi.org\/10.1007\/s11060-021-03890-9.","journal-title":"Journal neuro-oncology Dec"},{"issue":"1","key":"3455_CR40","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/bpa.12646","volume":"29","author":"FJ Rodriguez","year":"2019","unstructured":"Rodriguez FJ, Brosnan-Cashman JA, Allen SJ, et al. Alternative lengthening of telomeres, ATRX loss and H3-K27M mutations in histologically defined pilocytic Astrocytoma with anaplasia. Brain Pathol (Zurich Switzerland) Jan. 2019;29(1):126\u201340. https:\/\/doi.org\/10.1111\/bpa.12646.","journal-title":"Brain Pathol (Zurich Switzerland) Jan"},{"issue":"10","key":"3455_CR41","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1093\/jnen\/nlw074","volume":"75","author":"M Zanello","year":"2016","unstructured":"Zanello M, Pages M, Tauzi\u00e8de-Espariat A, et al. Clinical, imaging, histopathological and molecular characterization of anaplastic ganglioglioma. Journal Neuropathology Experimental Neurology Oct. 2016;75(10):971\u201380. https:\/\/doi.org\/10.1093\/jnen\/nlw074.","journal-title":"Journal Neuropathology Experimental Neurology Oct"},{"issue":"1","key":"3455_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s40478-022-01442-4","volume":"14","author":"C Mariet","year":"2022","unstructured":"Mariet C, Castel D, Grill J, et al. Posterior fossa ependymoma H3 K27-mutant: an integrated radiological and histomolecular tumor analysis. Acta Neuropathol Communications Sep. 2022;14(1):137. https:\/\/doi.org\/10.1186\/s40478-022-01442-4.","journal-title":"Acta Neuropathol Communications Sep"},{"key":"3455_CR43","doi-asserted-by":"publisher","unstructured":"Mendez FM, N\u00fa\u00f1ez FJ, Garcia-Fabiani MB et al. Epigenetic reprogramming and chromatin accessibility in pediatric diffuse intrinsic pontine gliomas: a neural developmental disease. Neuro-oncology. Feb 20. 2020;22(2):195\u2013206. https:\/\/doi.org\/10.1093\/neuonc\/noz218","DOI":"10.1093\/neuonc\/noz218"},{"issue":"1","key":"3455_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccell.2023.11.002","volume":"8","author":"C Koschmann","year":"2024","unstructured":"Koschmann C, Al-Holou WN, Alonso MM, et al. A road map for the treatment of pediatric diffuse midline glioma. Cancer Cell Jan. 2024;8(1):1\u20135. https:\/\/doi.org\/10.1016\/j.ccell.2023.11.002.","journal-title":"Cancer Cell Jan"},{"issue":"7","key":"3455_CR45","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1002\/ijc.32258","volume":"1","author":"S Mueller","year":"2019","unstructured":"Mueller S, Jain P, Liang WS, et al. A pilot precision medicine trial for children with diffuse intrinsic Pontine glioma-PNOC003: A report from the Pacific pediatric Neuro-Oncology consortium. International J cancer Oct. 2019;1(7):1889\u2013901. https:\/\/doi.org\/10.1002\/ijc.32258.","journal-title":"International J cancer Oct"},{"key":"3455_CR46","doi-asserted-by":"publisher","unstructured":"Patel J, Aittaleb R, Doherty R et al. Liquid Biopsy in H3K27M Diffuse Midline Glioma. Neuro-oncology. Dec 14. 2023;https:\/\/doi.org\/10.1093\/neuonc\/noad229","DOI":"10.1093\/neuonc\/noad229"},{"issue":"1","key":"3455_CR47","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40478-018-0580-7","volume":"15","author":"S Stallard","year":"2018","unstructured":"Stallard S, Savelieff MG, Wierzbicki K, et al. CSF H3F3A K27M Circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response. Acta Neuropathol Communications Aug. 2018;15(1):80. https:\/\/doi.org\/10.1186\/s40478-018-0580-7.","journal-title":"Acta Neuropathol Communications Aug"},{"issue":"1","key":"3455_CR48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41698-024-00535-8","volume":"22","author":"C Arthur","year":"2024","unstructured":"Arthur C, Carlson LM, Svoboda J, et al. Liquid biopsy guides successful molecular targeted therapy of an inoperable pediatric brainstem neoplasm. NPJ Precision Oncology Feb. 2024;22(1):44. https:\/\/doi.org\/10.1038\/s41698-024-00535-8.","journal-title":"NPJ Precision Oncology Feb"},{"issue":"23","key":"3455_CR49","doi-asserted-by":"publisher","first-page":"6266","DOI":"10.1158\/1078-0432.Ccr-20-2066","volume":"1","author":"AK Bruzek","year":"2020","unstructured":"Bruzek AK, Ravi K, Muruganand A, et al. Electronic DNA analysis of CSF Cell-free tumor DNA to quantify Multi-gene molecular response in pediatric High-grade glioma. Clinical cancer Research: Official J Am Association Cancer Research Dec. 2020;1(23):6266\u201376. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-20-2066.","journal-title":"Clinical cancer Research: Official J Am Association Cancer Research Dec"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03455-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03455-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03455-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:52:47Z","timestamp":1760071967000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-025-03455-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3455"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03455-y","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Beijing Tiantan Hospital (KY2024-139-01). All patients provided informed consent, and the study adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"283"}}